DAIC

APRIL 29, 2024

Getty Images milla1cf Mon, 04/29/2024 - 13:11 April 29, 2024 — Efforts by the American College of Cardiology , the American Heart Association , the Heart Failure Society of America , the Heart Rhythm Society and The Society for Cardiovascular Angiography & Interventions to create a new, independent Board of Cardiovascular Medicine under the American Board of Medical Specialties ( ABMS ) are closer to becoming a reality with the creation of a formal Board of Directors and the announcement by th

Certification 116

Certification Best Practices Heart Rhythm Heart Failure 116

Med Page Today

APRIL 29, 2024

(MedPage Today) -- The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first drug-eluting resorbable scaffold with.

Peripheral Arterial Disease 107

Peripheral Arterial Disease Stents Stent Ischemia 107

HCPLive

APRIL 29, 2024

Barratt explained findings from the phase 2b ORIGIN trial of atacicept and how it compares to current standard therapies in IgAN and other agents in the pipeline.

105

105

Med Page Today

APRIL 29, 2024

(MedPage Today) -- Cardiovascular death had a strong tie to the somatic mutations that often accrue with aging in people with subclinical atherosclerosis, an observational study found. For asymptomatic people who had atherosclerosis detected by.

Atherosclerosis 100

Atherosclerosis 100

HCPLive

APRIL 29, 2024

Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Angioplasty Stents Stent 111

Science Daily - Heart Disease

APRIL 29, 2024

Groundbreaking new research finds that an increased cardio fitness level will reduce your risk of death from any cause by nearly 20%.

Research 123

Research 123

HCPLive

APRIL 29, 2024

A combination of telemedicine and in-person visits led to a nearly 6% increase in electronic health record work for primary care physicians.

105

105

HCPLive

APRIL 29, 2024

A new study found a 2-week mindfulness-based intervention for patients with psoriasis does not improve skin status—it only helps the mind.

103

103

American College of Cardiology

APRIL 29, 2024

The American College of Cardiology Scientific Sessions 2024 (ACC.24), building on the successes and lessons of past gatherings, marked a significant return to in-person collaboration and learning for the Adult Congenital and Pediatric Cardiology (ACPC) community.

Pediatrics 60

Pediatrics Congenital Article 60

HCPLive

APRIL 29, 2024

FDA issued a CRL the abbreviated new drug application of ketamine, which had sought to enhance accessibility to the limited drug supply.

98

98

American College of Cardiology

APRIL 29, 2024

The following are key points to remember from an American Heart Association scientific statement, which reviews the pathology, imaging, and current treatment options for the tricuspid valve (TV).

Tricuspid 58

Tricuspid Article 58

HCPLive

APRIL 29, 2024

Findings indicated treatment with colchicine resulted in a significant reduction in mortality rate compared with placebo or standard care.

COVID-19 69

COVID-19 Outcomes 69

Frontiers in Cardiovascular Medicine

APRIL 29, 2024

Transcription factors (TFs) constitute an essential component of epigenetic regulation. They contribute to the progression of vascular diseases by regulating epigenetic gene expression in several vascular diseases. Recently, numerous regulatory mechanisms related to vascular pathology, ranging from general TFs that are continuously activated to histiocyte-specific TFs that are activated under specific circumstances, have been studied.

Aneurysm 52

Aneurysm Atherosclerosis Pulmonary Hypertension 52

HCPLive

APRIL 29, 2024

A recent study found breast arterial calcification on mammograms could help predict higher risk of stroke, cardiovascular death, and heart disease in women.

Heart Disease 59

Heart Disease Stroke Strokes 59

Frontiers in Cardiovascular Medicine

APRIL 29, 2024

IntroductionIntrahepatic cholestasis of pregnancy (ICP), the most prevalent liver disorder specific to pregnancy, affects approximately 1.5%-4% of pregnancies. However, the influence of ICP on cardiovascular disease (CVD), including hypertension (HTN) and coronary artery disease (CAD), has not been thoroughly investigated.MethodsThis study explores the causal relationship between ICP and CVD (HTN, CAD) using Mendelian Randomization (MR).

Cardiovascular Disease 52

Cardiovascular Disease Genetic predisposition Coronary Artery Disease Hypertension 52

HCPLive

APRIL 29, 2024

FDA approves mavorixafor (XOLREMDI) for WHIM syndrome, the first approved treatment for the rate disease.

72

72

Society of Thoracic Surgeons - Congenital

APRIL 29, 2024

Exhibitor Prospectus - 2024 STS Mastering Valve Surgery Workshop smccarthy Mon, 04/29/2024 - 10:59 Exhibitor Application Stand Out Among Your Competitors & Partners Increase your company’s opportunity for personalized interactivity with attendees by exhibiting at the Workshop. Several breaks will take place in the exhibit area and have been scheduled so that attendees have plenty of time to visit your booth.

Education 52

Education 52

HCPLive

APRIL 29, 2024

The announcement by Dermavant followed positive findings from the ADORING trials on tapinarof and an open label extension for children aged 2 - 17.

59

59

All About Cardiovascular System and Disorders

APRIL 29, 2024

The answer depends on what caused your high blood pressure. If it is a reversible cause which can be removed, then of course medications can be stopped. But if a reversible cause has not been found, you should be cautious about stopping medications. What are the reversible causes of high blood pressure? A transient drop in kidney function due to some illness (acute kidney injury) can raise the blood pressure.

Blood Pressure 52

Blood Pressure Diet Exercise General Cardiology 52

HCPLive

APRIL 29, 2024

Medical experts underscore disparities in diabetes treatment access, stressing the impact of insurance plans on treatment decisions, which can hinder patients and providers, especially when considering newer medications like GLP-1 agonists.

Diabetes 52

Diabetes 52

American College of Cardiology

APRIL 29, 2024

In this episode, Drs. Erin Michos and Leslie Cho discuss the research presented at ACC.24 related to statin intolerance and bempedoic acid. Dr. Cho’s research publication “Characteristics and Outcomes for Statin Intolerant Women Receiving Bempedoic Acid in The Clear Outcomes Trial” is discussed, as well as lipid management for women, Hispanic, Latinx, and obese patients in the CLEAR Outcomes Trial.

Obesity 56

Obesity Research Outcomes Article 56

HCPLive

APRIL 29, 2024

Key Opinion Leaders address the psychiatric issues associated with hypercortisolism and highlight crucial clinical symptoms to look for when diagnosing the condition, such as hypertension in patients under 30 without a family history, diabetes in those under 40 with no family history, and bone issues among other signs.

Diabetes 52

Diabetes Hypertension 52

American College of Cardiology

APRIL 29, 2024

What is the real-world lesion durability of pulmonary vein isolation (PVI) with pulsed-field ablation (PFA) among patients with clinically indicated redo procedures?

Pulmonary 56

Pulmonary Ablation Article 56

HCPLive

APRIL 29, 2024

Specialists in rheumatology, dermatology and gastrointestinal disease share their clinical experience on initiating or switching their patients on adalimumab biosimilars.

52

52

HeartRhythm

APRIL 29, 2024

It is with great sadness but also with honor we write in memory of our dear friend and colleague David E. Haines, MD. David passed away suddenly on February 10, 2024. He was a dear friend and colleague of the Heart Rhythm Society and electrophysiologists around the world. David’s many scholarly contributions focused on ablation energy sources, starting in 1986 when he was at the University of Virginia (UVA) and radiofrequency ablation was being introduced.

Best Practices 45

Best Practices Ablation Heart Rhythm Technology 45

HCPLive

APRIL 29, 2024

Specialists in rheumatology, dermatology and gastrointestinal disease discuss the evidence on efficacy and safety on switching patient to an adalimumab biosimilar.

52

52

HeartRhythm

APRIL 29, 2024

The first dual-chamber leadless pacemaker (DC-LP) system consists of two separate atrial and ventricular devices that communicate to maintain synchronous atrioventricular pacing and sensing. The initial safety and efficacy were previously reported.

Pacemaker 40

Pacemaker 40

HCPLive

APRIL 29, 2024

These data allow for a basis for additional research and possible interventions to address psoriasis patients’ demodicosis risk.

Research 59

Research 59

HeartRhythm

APRIL 29, 2024

Combined endo-epicardial catheter ablation is an established treatment for ventricular arrhythmias. Abnormal omnipolar voltage (OV) <1.5mV is a surrogate of underlying myocardial fibrosis/scar. Yet, epicardial adipose tissue (EAT) is a common confounder when interpretating epicardial OV maps and can result in “false” low voltage annotation even in the absence of scar.

Ablation 40

Ablation Arrhythmia 40

HCPLive

APRIL 29, 2024

Daniel Gaudet, MD, PhD, discusses SHASTA-2 data and what cardiologists could learn from the forthcoming 48-week MUIR trial data from EAS 2024.

52

52

Journal of Cardiothoracic Surgery

APRIL 29, 2024

There are various reconstructive methods after total sternectomy. Reproducibility is scarce due to overall small patient numbers. Therefore we present a standardized, interdisciplinary approach for thoracic an.

Research 40

Research 40

HCPLive

APRIL 29, 2024

Internal dysbiosis was present in 66% of patients at baseline and was more common among those with a disease duration of > 2 years.

52

52

Circulation: Cardiovascular Quality & Outcomes

APRIL 29, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Ischemic cardiomyopathy is the leading cause of heart failure (HF). Most patients do not undergo coronary assessment after HF diagnosis. There are no randomized clinical trials of coronary assessment after HF diagnosis.METHODS:Using an electronic health record cohort of all individuals with HF within the San Francisco Health Network from 2001 to 2019, we identified factors associated with coronary assessment.

Heart Failure 40

Heart Failure Coronary Artery Disease Outcomes Risk Factors 40

HCPLive

APRIL 29, 2024

Monosodium urate deposits significantly increased the risk of major cardiovascular events in patients with gout and hyperuricemia.

52

52

The American Journal of Cardiology

APRIL 29, 2024

Publication date: Available online 29 April 2024 Source: The American Journal of Cardiology Author(s): Apurva H Bharucha, Ritesh Kanyal, Michael Mullen, Kush Patel, David Smith, Joy Shome, Daniel J Blackman, Suleman Aktaa, Paul D Williams, Saib Khogali, Rafal Dworakowski, Mehdi Eskandari, Jonathan Byrne, Philip MacCarthy

Aortic valve 40

Aortic valve Aortic 40

HeartRhythm

APRIL 29, 2024

Pulsed field ablation (PFA) has emerged as a safe and effective alternative to thermal ablation modalities. Its tissue selectiveness stands out as a most important advantage over radiofrequency (RF) ablation or cryoablation, along with a shorter ablation time. Because of the multiple factors that drive the lesion formation, each report on PFA should be regarded as platform specific.

Ablation 40

Ablation 40

DAIC

APRIL 29, 2024

Getty Images milla1cf Mon, 04/29/2024 - 13:06 April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024 , a scientific congress of the European Society of Cardiology ( ESC ).1 “Cholesterol-lowering drugs save lives and prevent heart attacks, and should be prescribed to all patients with coronary artery disease,” said study author Dr.

Heart Disease 104

Heart Disease Cholesterol Heart Attack Heart attacks 104